5,000 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Purchased by Granite Bay Wealth Management LLC

Granite Bay Wealth Management LLC acquired a new position in Astrana Health, Inc. (NASDAQ:ASTH) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 5,000 shares of the company’s stock, valued at approximately $290,000.

Separately, Central Pacific Bank Trust Division acquired a new stake in shares of Astrana Health in the 3rd quarter worth about $160,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Stock Performance

Shares of ASTH opened at $59.48 on Friday. Astrana Health, Inc. has a 52-week low of $28.86 and a 52-week high of $59.89. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. The firm has a 50-day moving average price of $50.97 and a 200 day moving average price of $44.40. The firm has a market capitalization of $3.33 billion, a PE ratio of 45.06, a P/E/G ratio of 2.15 and a beta of 1.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.01. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The company had revenue of $486.30 million during the quarter, compared to analyst estimates of $440.68 million. During the same quarter last year, the firm posted $0.28 EPS. The business’s revenue for the quarter was up 39.7% on a year-over-year basis. On average, sell-side analysts anticipate that Astrana Health, Inc. will post 1.33 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ASTH has been the topic of a number of analyst reports. Truist Financial increased their price objective on shares of Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a report on Friday, August 9th. BTIG Research increased their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday. Stifel Nicolaus increased their target price on shares of Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. Finally, Robert W. Baird increased their target price on shares of Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a research report on Thursday, August 15th. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Astrana Health currently has an average rating of “Buy” and a consensus price target of $61.20.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.